Securing Reimbursement for Innovative Medical Technology

Many innovative medical technologies that gain FDA clearance end up as commercial failures because companies are unable to secure reimbursement. Securing adequate payment is often more difficult than gaining FDA clearance. This is complicated by the fact that each insurer is free to decide both what it will pay for, and how much it will pay.

View White Paper (PDF) →